FDA Inspection 1292172 — NATCO Pharma Limited Chemical Division Chennai
The FDA completed an inspection of NATCO Pharma Limited Chemical Division Chennai on November 21, 2025 in Chennai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 21, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chennai (India)